Company Profiles

driven by the PitchBook Platform

Arrien Pharmaceuticals

Description

Developer of treatments for neurodegenerative diseases. The company develops a small molecule targeted therapeutics drug discovery and development company working towards targeting kinase signaling pathways - A target class in treating neurodegenerative, Cancer, Inflammatory and Metabolic diseases.

2011

Founded

PRIVATE

Status

Angel

Latest Deal Type

1

Investors

Description

Developer of treatments for neurodegenerative diseases. The company develops a small molecule targeted therapeutics drug discovery and development company working towards targeting kinase signaling pathways - A target class in treating neurodegenerative, Cancer, Inflammatory and Metabolic diseases.

Website:

www.arrienpharma.com

Ownership Status

Privately held (backing)

Financing Status

Angel-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals
Drug Discovery
Drug Delivery
Discovery Tools (Healthcare)

Primary Office

120 Belmont Drive Suite 2 Somerset, NJ 08873United States +1 (732) 271-7000
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Arrien Pharmaceuticals's full profile, request a free trial.

    Arrien Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Arrien Pharmaceuticals Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Individual InvestorAngel (individual)Majority000 0000000 0000
    Individual Investor Angel (individual)

    Arrien Pharmaceuticals Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Hariprasad VankayalapatiC0-Founder
    Rajendra AppalaneniCo-Founder & Chief Executive Officer
    Hariprasad Vankayalapati C0-Founder
    Rajendra Appalaneni Co-Founder & Chief Executive Officer
    Request full access to PitchBook